For Clinicians
Physician Education Center
A hub of educational resources for physicians and clinicians who want to understand the current evidence base, regulatory status, mechanism, and clinical role of magnetic duodeno-ileostomy (MagDI) and related procedures.
Written by MagnaMetabolic Editorial Team Medically reviewed by Ariel Ortiz, MD — Bariatric & Metabolic Surgery Last reviewed: June 7, 2026
Recommended starting points
- FDA & Regulatory Status
- Mechanism of Action
- Published Clinical Studies
- Safety & Risks
- Ongoing Clinical Trials
Continuing education
For information on case observation, proctoring, or educational visits at OCC and the Ariel Center, please use the contact form. We collaborate with bariatric and metabolic surgery societies and welcome dialogue with clinicians evaluating MagDI in their own practice.
Evidence
Scientific References
Selected primary sources informing this page. External links open in a new tab; we do not control or endorse third-party content.
- FDAU.S. FDA — De Novo Classification DEN240013: MagDI System (Magnetic Duodeno-Ileostomy), De Novo marketing authorization granted July 2, 2024.
- FDAU.S. FDA — 510(k) Premarket Notification K242086: MagDI System (second generation), clearance granted October 24, 2024.
- Obesity SurgeryGagner M, et al. First-in-human experience of magnetic duodeno-ileostomy for the treatment of obesity and metabolic disease. Obesity Surgery.
- Surgical EndoscopyMulti-center early outcomes of sleeve gastrectomy combined with magnetic duodeno-ileostomy (Sleeve Plus MagDI). Surgical Endoscopy.
- SOARDMagnetic duodeno-ileal anastomosis after previous sleeve gastrectomy for weight regain, insufficient weight loss, or diabetes recurrence. Surgery for Obesity and Related Diseases (SOARD).
- ASMBSAmerican Society for Metabolic and Bariatric Surgery (ASMBS) and IFSO 2022 indications for metabolic and bariatric surgery.